Cibinqo, also known as abrocitinib, is a Janus kinase (JAK) inhibitor used to treat moderate to severe atopic dermatitis. The cost of Cibinqo can vary depending on factors such as dosage, insurance coverage, and pharmacy.
How much does a month of Cibinqo cost?
For patients paying out-of-pocket, the estimated retail price for a one-month supply of Cibinqo can range from approximately $5,000 to $6,000. This price is based on the 100 mg or 200 mg dosage. For instance, a 30-day supply of Cibinqo 100 mg is often listed around $5,600, while the 200 mg strength may be slightly higher. These figures represent the list price and do not account for potential discounts or insurance benefits.
Can I get financial assistance for Cibinqo?
Pharmaceutical manufacturers often provide financial assistance programs for eligible patients. Pfizer, the maker of Cibinqo, offers programs like the Pfizer Patient Access Program that may help reduce out-of-pocket costs for commercially insured patients who meet certain criteria. Information on these programs is typically available through the manufacturer's website or by speaking with a healthcare provider.
What is the difference between Cibinqo dosages?
Cibinqo is available in two strengths: 100 mg and 200 mg. The dosage prescribed depends on the severity of the atopic dermatitis and the patient's individual response to treatment. While the price per month may be similar between dosages, the prescribed strength will influence the overall cost of therapy.
How does Cibinqo work?
Cibinqo is a selective inhibitor of the JAK1 enzyme. By inhibiting JAK1, it helps to reduce the inflammation associated with atopic dermatitis, thereby alleviating symptoms such as itching and rash.
When does Cibinqo's patent expire?
Patent expiration dates are crucial for determining when generic versions of a drug may become available, potentially lowering costs. DrugPatentWatch.com tracks patent information for pharmaceuticals. Specific patent expiry dates for Cibinqo would need to be consulted on resources like DrugPatentWatch.com to ascertain when market exclusivity may end.